2m 2m 2m 2m 2m 2m 2m
TSCAN THERAPEUT (TCRX)
NASDAQ
$0.32+$0.0005 (+0.16%)
Price as of Oct 02, 2026 6:59 PM EDT- $20.2MMarket Cap
- -85.44%1-Year Change
- BiotechnologyIndustry
TSCAN THERAPEUT (TCRX)
$0.32+$0.0005 (+0.16%)
TCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.32 | ||
Change | +$0.003 (+0.95%) | ||
Open | $0.32 | ||
High | $0.33 | ||
Low | $0.31 | ||
Previous Close | $0.31 | ||
Volume | 624,803 | ||
30-Day Average Volume | 1,316,753 | ||
1-Week Change | -9.03% | ||
1-Month Change | -52.35% | ||
1-Year Change | -85.44% | ||
3-Year Change | -87.60% | ||
5-Year Change | -96.32% | ||
Fundamentals | |||
Shares Outstanding | 63.5M | ||
Total Assets | $171.5M | ||
Market Cap | $20.2M | ||
Enterprise Value | -$47.2M | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$30.4M | ||
Free Cash Flow | -$28.0M | ||
EBIT | -$29.7M | ||
EBITDA | -$29.0M | ||
Net Working Capital | $73.4M | ||
EPS | -$0.23 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | -45 | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue